TVTX - Travere Therapeutics Non-GAAP EPS of $0.94 beats by $1.86 revenue of $45.05M beats by $3.23M
2024-02-15 16:05:21 ET
More on Travere Therapeutics
- Travere Therapeutics: Restructuring Away From Disaster
- Travere Therapeutics Q4 2023 Earnings Preview
- Travere inks licensing deal for sparsentan in Asia
- Seeking Alpha’s Quant Rating on Travere Therapeutics
- Historical earnings data for Travere Therapeutics